Structures by: Majumder M.
Total: 8
C16H26Cl2CuN6O8
C16H26Cl2CuN6O8
Dalton transactions (Cambridge, England : 2003) (2020) 49, 24 8282-8297
a=11.562(3)Å b=14.067(4)Å c=13.652(4)Å
α=90° β=91.830(4)° γ=90°
C18H26Cl2CuN6O8
C18H26Cl2CuN6O8
Dalton transactions (Cambridge, England : 2003) (2020) 49, 24 8282-8297
a=11.822(2)Å b=13.985(3)Å c=13.983(3)Å
α=90° β=93.685(2)° γ=90°
Indomethacin Nicotinamide (1/1)
C19H16ClNO4,C6H6N2O
CrystEngComm (2013) 15, 20 4041
a=17.1980(8)Å b=5.0156(2)Å c=27.3815(15)Å
α=90° β=97.311(2)° γ=90°
5H-dibenz(b,f)azepine-5-carboxamide 2-(1-((4- chlorophenyl)carbonyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid (1/1)
C15H12N2O1,C19H16Cl1N1O4
CrystEngComm (2011) 13, 21 6327
a=10.2447(3)Å b=29.148(1)Å c=10.2114(3)Å
α=90° β=106.636(2)° γ=90°
C10H10O4
C10H10O4
ACS omega (2019) 4, 3 5221-5232
a=14.7048(11)Å b=5.6391(4)Å c=21.9019(16)Å
α=90° β=90° γ=90°
C42H38Co2N2O12
C42H38Co2N2O12
ACS omega (2019) 4, 3 5221-5232
a=21.550(2)Å b=10.5223(8)Å c=19.2508(16)Å
α=90° β=116.538(9)° γ=90°
C42H38Mn2N2O12
C42H38Mn2N2O12
ACS omega (2019) 4, 3 5221-5232
a=21.5201(9)Å b=10.5500(5)Å c=19.5452(8)Å
α=90° β=117.251(2)° γ=90°
C42H38N2O12Zn2
C42H38N2O12Zn2
ACS omega (2019) 4, 3 5221-5232
a=21.5019(11)Å b=10.4986(5)Å c=19.2899(11)Å
α=90° β=116.769(4)° γ=90°